Brand names: Aphthasol®
Chemical formula:

Amlexanox oral patch
What is Amlexanox oral patch?
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:How should this medicine be used?
Amlexanox is applied to aphthous ulcers (canker sores) of the mouth only; do not apply to ulcers in eyes or other areas. Wash eyes promptly with clear running water if they should come into contact with the amlexanox patch. Wash hands before and immediately after applying amlexanox oral patch. Begin applying the patch as soon as possible after noticing the symptoms of an aphthous ulcer. Follow the directions on the prescription label. Brush your teeth and then apply amlexanox, usually after breakfast, lunch, dinner and at least 80 minutes before bedtime. Press one patch onto each ulcer in the mouth using gentle pressure. Only treat up to 3 ulcers at a time. Do not eat or drink for 1 hour after each patch application. Use the patch until the ulcer heals or up to 10 days.What if I miss a dose?
What drug(s) may interact with Amlexanox?
What should I watch for while taking Amlexanox?
What side effects may I notice from receiving Amlexanox?
Side effects that you should report to your prescriber or health care professional as soon as possible:Where can I keep my medicine?
Keep this medicine out of the reach of children.Last updated: 2/27/2004 10:25:00 AM
Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.
| Systematic (IUPAC) name | |
|---|---|
| 2-amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid | |
| Clinical data | |
| Trade names | Aphthasol |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a601017 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Topical |
| Pharmacokinetic data | |
| Half-life | 3.5 hours |
| Excretion | Renal (17%) |
| Identifiers | |
| CAS number | 68302-57-8 |
| ATC code | A01AD07 R03DX01 |
| PubChem | CID 2161 |
| DrugBank | DB01025 |
| ChemSpider | 2076 |
| UNII | BRL1C2459K |
| KEGG | D01828 |
| ChEBI | CHEBI:31205 |
| ChEMBL | CHEMBL1096 |
| Chemical data | |
| Formula | C16H14N2O4 |
| Mol. mass | 298.293 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Amlexanox (trade name Aphthasol) is a medication with antiallergic and anti-inflammatory effects used in the treatment of aphthous ulcers (canker sores). Amlexanox is also available in Japan as oral tablets (trade name Solfa) for treatment of bronchial asthma, where it has been marketed by the Takeda Pharmaceutical Company since 1987, though Aphthtab by Egyptian Eva pharma also exist. In India it is available as Lexanox by Macleods Pharmaceuticals Ltd. In Bangladesh it is marketed by Square Pharmaceuticals as Apsol.
|
|||||||||||||||||||
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)